SCHEMBL8340613

SCHEMBL8340613

CCCCN(C(=O)C(CC)c1ccc(OC)c(N=S(=O)=O)c1)C(=S)NC

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MAPT P10636 3/20 0.33
▸ GLA P06280 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ KCNQ2 O43526 1/20 0.31
▸ LMNA P02545 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ AKR1C3 P42330 3/20 0.30
▸ AKR1C2 P52895 3/20 0.30
▸ L3MBTL1 Q9Y468 2/20 0.30
▸ AKR1C1 Q04828 1/20 0.30
▸ PTGS1 P23219 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ RECQL P46063 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ TAS1R3 Q7RTX0 1/20 0.30
▸ TAS1R1 Q7RTX1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8340889 0.92 SMN1; SMN2 (0.36) SMN1; SMN2MAPTGLAALDH1A1NPSR1
SCHEMBL8336116 0.90 SMN1; SMN2 (0.35) SMN1; SMN2MAPTGLAALDH1A1NPSR1
SCHEMBL8339753 0.88 — —
SCHEMBL8340153 0.87 SMN1; SMN2 (0.35) SMN1; SMN2MAPTGLAALDH1A1NPSR1
SCHEMBL8336974 0.86 SMPD1 (0.34) SMN1; SMN2L3MBTL1GAATDP1
SCHEMBL8334645 0.86 SMPD1 (0.34) SMN1; SMN2L3MBTL1GAATDP1
SCHEMBL8335988 0.86 SMPD1 (0.34) SMN1; SMN2L3MBTL1GAATDP1
SCHEMBL8333474 0.84 NPSR1 (0.33) SMN1; SMN2MAPTGLAALDH1A1NPSR1
SCHEMBL8336550 0.82 GAA (0.38) MAPTLMNAKMT2AL3MBTL1GAA
SCHEMBL8334662 0.81 SMN1; SMN2 (0.37) SMN1; SMN2MAPTGLAALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback